Gemcitabine and Abraxane

DRUG2 trials

Sponsors

Pancreatic Cancer Research Team, Georgetown University

Conditions

Pancreatic CancerResectable Pancreatic Cancer

Phase 2

Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

CompletedNCT01298011

Pancreatic Cancer Research TeamResectable Pancreatic Cancer

Start: 2011-05-31End: 2015-05-31Updated: 2015-06-17

Study of Gemcitabine and Abraxane for Pancreas Cancer

TerminatedNCT02242409

Georgetown UniversityPancreatic Cancer

Start: 2014-09-30End: 2016-12-31Updated: 2017-02-14